BioCentury
ARTICLE | Finance

Next in line

WuXi NextCODE's $75 million series B could fuel path to IPO

May 6, 2017 1:25 AM UTC

WuXi NextCODE Genomics Inc. could be the final New WuXi Life Science Ltd. subsidiary to head for an IPO.

NextCODE, one of three New WuXi subsidiaries, announced May 1 that it raised $75 million in a series B round co-led by Temasek and Yunfeng Capital, with participation from Amgen Ventures and 3W Partners. ...

BCIQ Company Profiles

New WuXi Life Science Ltd.